BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30255698)

  • 1. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
    Mehta A; Goswami M; Sinha R; Dogra A
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2447-2453. PubMed ID: 30255698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
    Mehta A; Goswami M; Sinha R
    Ann Clin Lab Sci; 2017 Mar; 47(2):129-135. PubMed ID: 28442513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
    Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
    Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
    Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
    Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential clinical impacts of tumour budding evaluated by the use of immunohistochemical and haematoxylin and eosin staining in stage II colorectal cancer.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Shimazaki H; Hase K; Ueno H
    Histopathology; 2019 Jun; 74(7):1005-1013. PubMed ID: 30698857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis between multilevel sectioning with conventional haematoxylin and eosin staining and immunohistochemistry for detecting nodal micrometastases with stage I and II colorectal cancers.
    Wong YP; Shah SA; Shaari N; Mohamad Esa MS; Sagap I; Isa NM
    Asian Pac J Cancer Prev; 2014; 15(4):1725-30. PubMed ID: 24641399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods.
    Fisher NC; Loughrey MB; Coleman HG; Gelbard MD; Bankhead P; Dunne PD
    Histopathology; 2022 Feb; 80(3):485-500. PubMed ID: 34580909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
    Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
    Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node study in colorectal cancer using serial sectioning and Hematoxylin-Eosin staining: importance and limitations.
    Vîlcea ID; Vasile I; Mirea CS; Meşină C; Enache SD; Tenovici M; Mogoantă S; Ghiţă C
    Rom J Morphol Embryol; 2011; 52(1 Suppl):379-83. PubMed ID: 21424078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
    Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
    Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
    Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
    Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
    Archilla I; Díaz-Mercedes S; Aguirre JJ; Tarragona J; Machado I; Rodrigo MT; Lopez-Prades S; Gorostiaga I; Landolfi S; Alén BO; Balaguer F; Castells A; Camps J; Cuatrecasas M
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00303. PubMed ID: 33939382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma.
    Fuchinoue K; Nemoto T; Shimada H; Tochigi N; Igarashi Y; Yajima S; Suzuki T; Oshima Y; Shibuya K
    Esophagus; 2020 Apr; 17(2):168-174. PubMed ID: 31595396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
    Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
    Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
    Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
    J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer.
    Cai J; Ikeguchi M; Maeta M; Kaibara N
    Surgery; 2000 Jan; 127(1):32-9. PubMed ID: 10660756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.